Time Course of Immunosuppression Minimization and HLA Class I and Class II Antibody Emergence in Heart Transplantation

被引：0
|
作者：
Bakir, M. [1 ]
Henriquez-Ticas, D. [1 ]
Chang, E. [1 ]
Maque, J. [1 ]
Chittoor, J. [1 ]
Starling, C. [2 ]
Bondar, G. [1 ]
Wisniewski, N. [1 ]
Adigopula, S. [1 ]
Khuu, T. [1 ]
Reed, E. [1 ]
Zhang, J. [1 ]
Cadeiras, M. [1 ]
Deng, M. [1 ]
机构：
[1] Univ Calif Los Angeles, Cardiol, Los Angeles, CA USA
[2] LMU, Cardiol, Los Angeles, CA USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2015年 / 34卷 / 04期
关键词：
D O I：
10.1016/j.healun.2015.01.352
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
338
引用
收藏
页码：S131 / S132
页数：2
相关论文
共 50 条
  • [21] THE TIME COURSE OF ANTI-HLA ANTIBODY DEVELOPMENT FOLLOWING HEART TRANSPLANTATION
    Shiozaki, R.
    Liou, F.
    Siddiqui, S.
    Hamilton, M.
    Kobashigawa, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2015, 63 (01) : 113 - 114
  • [22] Clinical relevance of presensitization against HLA class I and class ii in the modern kidney transplantation era
    Süsal, C
    Opelz, G
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V11 - V11
  • [23] High resolution typing for HLA class I and class II antigens for unrelated bone marrow transplantation
    Bacigalupo, A
    Lamparelli, T
    Gualandi, F
    Oochini, D
    Berisso, G
    Bregante, S
    Raiola, AM
    Frassoni, F
    Lombardi
    Van Lint, MT
    Bruno, B
    Oneto, R
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (07) : 130 - 130
  • [24] HLA class I peptide polymorphisms contribute to class II DQβ0603:DQα0103 antibody specificity
    N. Remi Shih
    Thoa Nong
    Cathi Murphey
    Mayra Lopez-Cepero
    Peter W. Nickerson
    Jean-luc Taupin
    Magali Devriese
    Jakob Nilsson
    Marie-Benedicte Matignon
    Robert A. Bray
    Jar-How Lee
    Nature Communications, 15
  • [25] OUTCOME OF DESENSITIZATION IN HLA CLASS II AS COMPARED WITH CLASS I DONOR SPECIFIC ANTIBODY (DSA): A PROSPECTIVE STUDY
    Al Meshari, Khalid
    Pall, Abeed
    Chaballout, Ahmed
    El Gamal, Hazem
    Al Mana, Hadeel
    Ali, Tariq
    Alzayer, Fadi
    Al Talhi, Mai
    TRANSPLANT INTERNATIONAL, 2013, 26 : 39 - 39
  • [26] Steps towards Personalization of Clinical Care in Era of Precision Medicine. Time Dependent Immune Phenomapping in Heart Transplantation and Emergence of Anti-HLA Class I and II Antibodies
    Bakir, M.
    Jackson, N.
    Chang, E.
    Henriquez, D.
    Tseng, C.
    Starling, C.
    Khuu, T.
    Cruz, D.
    DePasquale, E.
    Ardehali, R.
    Zhang, J.
    Schaenman, J.
    Kubak, B.
    Kwon, M.
    Ardehali, A.
    Reed, E.
    Deng, M.
    Cadeiras, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04) : S201 - S202
  • [27] HLA class I peptide polymorphisms contribute to class II DQβ0603:DQα0103 antibody specificity
    Shih, N. Remi
    Nong, Thoa
    Murphey, Cathi
    Lopez-Cepero, Mayra
    Nickerson, Peter W.
    Taupin, Jean-luc
    Devriese, Magali
    Nilsson, Jakob
    Matignon, Marie-Benedicte
    Bray, Robert A.
    Lee, Jar-How
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [28] HLA CLASS-I AND CLASS-II EXPRESSION IN RHABDOMYOSARCOMAS
    FERNANDEZ, JE
    CONCHA, A
    ARANEGA, A
    RUIZCABELLO, F
    CABRERA, T
    GARRIDO, F
    IMMUNOBIOLOGY, 1991, 182 (05) : 440 - 448
  • [29] HLA class I and class II allele and haplotype diversity in Martinicans
    Bera, O
    Cesaire, R
    Quelvennec, E
    Quillivic, F
    de Chavigny, V
    Ribal, C
    Semana, G
    TISSUE ANTIGENS, 2001, 57 (03): : 200 - 207
  • [30] HLA class I and class II polymorphism in the population of Rijeka, Croatia
    Crnic-Martinovic, M
    Vujaklija-Stipanovic, K
    Ristic, S
    Fucak, M
    Kapovic, M
    Weiner, M
    Sepcic, J
    COLLEGIUM ANTROPOLOGICUM, 2002, 26 (01) : 69 - 75
12345